ARTICLE | Company News
Amarillo, Intas deal
October 12, 2009 7:00 AM UTC
Intas received rights to develop and commercialize Amarillo's Veldona interferon alpha to prevent seasonal influenza A (H1N1) and swine influenza A (H1N1) in India and Nepal. Intas will sponsor India...